Back
Seres Therapeutics Quote, Financials, Valuation and Earnings
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
14
MCRB
Seres Therapeutics
Last Price:
0.56
Seasonality Move:
-9.46%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.Seres Therapeutics Price Quote
$0.56
-0.03 (-4.39%)
(Updated: April 19, 2024 at 5:05 PM ET)
Seres Therapeutics Key Stats
Sell
14
Seres Therapeutics (MCRB)
is a Sell
Day range:
$0.58 - $0.63
52-week range:
$0.58 - $6.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.60
P/B ratio:
0%
Volume:
3.7M
Avg. volume:
4.1M
1-year change:
-90.3%
Market cap:
$88.4M
Revenue:
$126.3M
EPS:
$-0.9
How Much Does Seres Therapeutics Make?
-
How Much Are Seres Therapeutics's Sales Annually?
MCRB Revenues are $126.3M -
How Much Profit Does Seres Therapeutics's Make A Year?
MCRB net income is -$113.7M
Is Seres Therapeutics Growing As A Company?
-
What Is Seres Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.93% -
What Is Seres Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Seres Therapeutics Stock Price Performance
-
Did Seres Therapeutics Stock Go Up Last Month?
Seres Therapeutics share price went down by -22.76% last month -
Did MCRB's Share Price Rise Over The Last Year?
MCRB share price fell by -90.3% over the past 1 year
What Is Seres Therapeutics 52-Week High & Low?
-
What Is Seres Therapeutics’s 52-Week High Share Price?
Seres Therapeutics has traded as high as $6.73 over the past 52 weeks -
What Is Seres Therapeutics’s 52-Week Low Share Price?
Seres Therapeutics has traded as low as $0.58 over the past 52 weeks
Seres Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Seres Therapeutics?
-
How Much Debt Does Seres Therapeutics Have?
Total long term debt quarterly is $101.5M -
How Much Cash Does Seres Therapeutics Have?
Cash and short term investments quarterly total is $128M -
What Is Seres Therapeutics’s Book Value Per Share?
Book value per share is -0.33
Is Seres Therapeutics Cash Flow Positive?
-
What Is MCRB Cash Flow From Operations?
Cash flow from operations (TTM) is -$117.4M -
What Is Seres Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $71.7M -
What Is Seres Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $10.6M
Seres Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
MCRB return on invested capital is -171.66% -
What Is Seres Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -32.46% -
What Is MCRB Return On Equity?
ROE is a measure of profitability and is 0%
Seres Therapeutics Earnings Date & Stock Price
-
What Is Seres Therapeutics's Stock Price Today?
A single share of MCRB can be purchased today for 0.59 -
What Is Seres Therapeutics’s Stock Symbol?
Seres Therapeutics trades on the nasdaq under the ticker symbol: MCRB -
When Is Seres Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Seres Therapeutics is scheduled on May 9, 2024 -
When Is MCRB's next ex-dividend date?
Seres Therapeutics's next ex-dividend date is April 19, 2024 -
How To Buy Seres Therapeutics Stock?
You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Seres Therapeutics Competitors
-
Who Are Seres Therapeutics's Competitors?
Below is a list of companies who compete with Seres Therapeutics or are related in some way:
Seres Therapeutics Dividend Yield
Data Unavailable
Seres Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 51.29% |
| Revenue: | -93.44% | 135.39% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 7.22 |
| Upside from Last Price: | 1132.71% |